A prospective evaluation of oral Yunnan Baiyao therapy on thromboleastographic parameters in apparently healthy dogs. Issue 3 (4th May 2018)

• Record Type: Journal Article
• Authors: Tansey, Colleen; Wiebe, Melissa L.; Hybki, Gabrielle C.; Patlogar, Jeffrey E.; Murphy, Lisa A.; Bianco, Domenico; Nakamura, Reid K.
• Is Part Of: Journal of veterinary emergency and critical care. Volume 28:Issue 3(2018)
• Page Start: 221
• Page End: 225
• Publication Date: 2018-05-04
• Subjects: hemostatic agent -- procoagulant -- viscoelastic testing; Veterinary emergencies -- Periodicals; Veterinary critical care -- Periodicals; 636.089
• DOI: 10.1111/vec.12712
• Languages: English
• ISSNs: 1479-3261

Abstract

Abstract: Objective: To determine the effect of Yunnan Baiyao (YB) on hemostatic parameters measured by thromboelastography (TEG) in healthy dogs administered 1 capsule of YB orally twice daily for 1 week. Design: Prospective study of client‐owned dogs at a small animal specialty hospital. Setting: Private referral center. Animals: Eighteen client‐owned adult dogs weighing at least 15 kg. Interventions: Dogs had a baseline TEG performed and then each dog was administered 1 capsule of YB twice daily by mouth for 1 week and the TEG was reevaluated. Any side effects attributed to YB were noted at this time. Measurements and Main Results: All 18 enrolled dogs completed the study. Dogs that received 1 capsule (250 mg/capsule) of YB orally twice daily had significantly increased G as well as A30 and A60 values. There was also a significantly decreased LY30 and LY60 values after 1 week. The YB appeared well tolerated as only one dog developed mild diarrhea. Conclusions: The results of this study suggest that YB at 1 capsule orally twice daily in healthy medium to large breed dogs increases the strength of the clot as measured by TEG and that YB was apparently well tolerated in the study population reported here. Larger prospective studies in different disease states are warranted to further evaluate these preliminary findings.